Let’s start with an SAT question as old as this world that we call Planet Earth, assuming the SATs were around thousands of years ago when man was staying warm by humping a Buysellatops until they were feeling bi and sore. Which number doesn’t belong: A) 21.4% B) 21.7% C) There’s no C. D) 5.7%. If you answered C, I hope your folks are rich so you can get into an accredited college. Just think, after you graduate you can put Harvard on your resume just like everyone else new to the workforce. If you answered A because it’s the only even number, you’re overthinking; odds and evens is something you can forget after elementary school unless you plan on working the roulette table. If you answered B, because it’s the only B, at least you can get your pants on in the morning. They are on backwards though. If you answered D, you’re right. Those are Matt Kemp‘s last three years of homers per fly ball. 5.7% is silly bad. Last year that would’ve put him in the company of Alexei Ramirez and Michael Young. If there was no offseason shoulder surgery for Matt Kemp, that number alone would mean Kemp is a huge buy low. Of course, there was the surgery and his home run distance is down. He’s not driving the ball as far as he has in previous years. So, as I said in this week’s fantasy baseball podcast, I’m buying Kemp for the first time in about two years. I’m only buying him because his value is so low. I’m not buying him for 1st, 2nd, 3rd or 4th, 5th round talent. I’d want a discount, but I’d still buy. Look at a guy like Justin Upton last year. He was nursing an injury, then hit 9 homers in the last six weeks of the season. I wouldn’t be surprised to see Kemp do something similar. He could easily regain some strength as the season progresses and hit 17-20 homers in the final two months with 15 steals. He’s still a risky play because of the injuries, but for the right price, I’m buying. Anyway, here’s some more players to Buy or Sell this week in fantasy baseball:
Please, blog, may I have some more?